Praxis Precision Medicines, Inc (PRAX)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Marcio Souza |
| Employees: | 110 |
| Web site: | praxismedicines.com |
|
99 HIGH STREET, 30TH FLOOR, BOSTON, MA, 02110
617-300-8460
| |
| Date | Ratio |
|---|---|
| 2023-11-29 | 1:15 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression.
Please log in first to see chart